advertisement

Topcon

Tian J 14

Showing records 1 to 14 | Display all abstracts from Tian J

106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Shi Y
British Journal of Ophthalmology 2023; 107: 221-226
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Liu H
The Lancet. Global health 2023; 11: e456-e465
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Oatts J
British Journal of Ophthalmology 2023; 107: 221-226
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Li R
The Lancet. Global health 2023; 11: e456-e465
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Tian J
British Journal of Ophthalmology 2023; 107: 221-226
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Zhang Y
The Lancet. Global health 2023; 11: e456-e465
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Qiao C
British Journal of Ophthalmology 2023; 107: 221-226
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Zhang K
The Lancet. Global health 2023; 11: e456-e465
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Zhang Q
British Journal of Ophthalmology 2023; 107: 221-226
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Yusufu M; Liu Y
The Lancet. Global health 2023; 11: e456-e465
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Han Y
British Journal of Ophthalmology 2023; 107: 221-226
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Mou D
The Lancet. Global health 2023; 11: e456-e465
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Wang N
British Journal of Ophthalmology 2023; 107: 221-226
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Chen X; Tian J; Li H; Fan S; Tang J; Wang N
The Lancet. Global health 2023; 11: e456-e465

Issue 23-4

Change Issue


advertisement

Oculus